Amgen Receives Positive CHMP Opinion To Expand Use Of Prolia® (denosumab) To Patients With Glucocorticoid-Induced Osteoporosis
Amgen (NASDAQ:AMGN) today announced that...
Read MoreAmgen (NASDAQ:AMGN) today announced that...
Read MoreSun Pharma Consumer Healthcare (CHC),...
Read MoreThis World Asthma Day, AstraZeneca...
Read MoreThromboGenics NV (Euronext Brussels: THR),...
Read MoreInternational Biophysics Corporation, a global...
Read MoreMobius Imaging, LLC, announced today...
Read MoreThe European Medicines Agency (EMA)...
Read MoreZydus Cadila has received the...
Read More